WENDI SHAFFMASTER: Open Payments
NPI 1760883847 · RICHMOND, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,047 in 58 payments from 14 companies in 2025. Trend: 2023 $197 · 2024 $1,439 · 2025 $1,047
Food & beverage: $996Education: $51
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 21 | $272 |
| AstraZeneca Pharmaceuticals LP | 11 | $243 |
| GENZYME CORPORATION | 8 | $146 |
| Baxter Healthcare | 2 | $64 |
| Regeneron Healthcare Solutions, Inc. | 2 | $53 |
| Amgen Inc. | 2 | $48 |
| Verona Pharma, Inc. | 3 | $45 |
| Insmed, Inc. | 2 | $39 |
| Viatris Specialty LLC | 2 | $38 |
| Grifols USA, LLC | 1 | $31 |
Products named: DUPIXENT, NUCALA, TRELEGY ELLIPTA, FASENRA, BREZTRI, Hillrom - Monarch Airway Clearance System, TEZSPIRE, Ohtuvayre.
Industry payments across IN — which companies pay providers there.
